The Importance of Access
Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).
This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques.
What does the AAM do – and why are you so passionate about its cause?
The Association for Accessible Medicines is a Washington DC-based trade association that represents generic drug and biosimilar manufacturers. We advocate for policies to ensure that patients have access to safe, effective and affordable medications. Our members are manufacturers, and we regularly engage with them for policy and legislative proposals regarding healthcare and prescription drug costs, and FDA issues. We start from the premise that no medicine is effective if patients cannot access it.
For me, it has always come down to the importance of patient access. I am a true believer in the value the pharma industry provides – both in terms of new medicine development and the competition among manufacturers that increases overall accessibility and affordability. We're actually celebrating the 35th birthday of landmark legislation known as the Hatch-Waxman law (officially, the Drug Price Competition and Patent Term Restoration Act), which created our modern pathway for generics in the US market. This single act has allowed the industry to deliver hundreds of billions of dollars of savings every year to the US healthcare system. Remarkably, over the last decades, the total saving has grown to nearly $2 trillion, which is an astounding value proposition unseen in any other area of healthcare.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.